Document:

exv10w1

 

EXHIBIT 10.1

			
	
	 	Shirley J. Hughes

Senior Vice President

Human Resources
	 	 
	 	Ceridian Corporation

3311 East Old Shakopee Road

Minneapolis, MN 55425-1640

952/853-3301

Fax: 952/853-3312

shirley.j.hughes@ceridian.com

AMENDED OFFER LETTER

PRIVATE/CONFIDENTIAL

December 6, 2004

Mr. Douglas C. Neve

10797 Purdey Road

Eden Prairie, MN 55347

Dear Mr. Neve:

Ceridian Corporation is pleased to offer you employment as Executive Vice President and Chief
Financial Officer, reporting to Ronald L. Turner, Chairman, President and CEO. Your office will be
located in Bloomington, Minnesota. Your base salary stated on an annualized basis will be
$400,000. You will be eligible to participate in the Ceridian Executive Incentive Plan with a
target annual payout, based on performance, of 80% of your year-end annualized salary with a
maximum payout of 110% at superior performance. Details of the 2005 Ceridian Executive Incentive
Plan will be communicated to you at a later date. For calendar year 2005 only, you are guaranteed
a target bonus payment.

In this position you will receive an annual supplemental cash adder of $25,000 paid on the regular
payroll cycle. The purpose of the supplemental cash adder is to provide you the opportunity to
purchase those perquisites most important to you (e.g., financial counseling, tax assistance,
etc.).

Upon hire, you will be recommended to the Compensation and Human Resources Committee of the Board
of Directors for a stock award, consisting of 135,000 stock options and 21,700 full value
restricted shares of Ceridian common stock (this combined award of stock options and restricted
shares is equivalent to 200,000 stock options). The option price will be equal to the fair market
value on the date of hire. Upon hire you will receive additional information regarding the grants
and applicable vesting schedules along with other details.

 

 

Mr. Douglas C. Neve

Amended Offer Letter

December 6, 2004

Page 2

You will receive an executive employment agreement which provides two years of compensation
protection in the event of involuntary loss of job, for reasons other than cause, and three years
of income protection in the event of a change of control and loss of job. The agreement has
non-competition, confidentiality and non-recruitment provisions.

You will also receive additional benefits including one extra week of vacation over the normal
Ceridian schedule, an annual physical at Mayo Clinic for you and your spouse, and a company-paid,
portable, Long-Term Care insurance policy for you, and also for your wife with evidence of
insurability.

After hire, we will develop an individual Supplemental Executive Retirement Plan (SERP), consistent
with Plans for similar officers. The plan is subject to final approval by the Compensation and
Human Resources Committee of the Board of Directors.

In compliance with the Immigration Reform and Control Act of 1986, you are required to complete the
Employment Eligibility Verification Form I-9 at the time of hire. You will be required to provide
documents establishing your identity and employment eligibility. Examples of acceptable documents
include: U.S. Passport, Certificate of U.S. Citizenship, driver’s license and social security card
or birth certificate. Please bring the appropriate documents with you on your first day.

As a condition of your employment with Ceridian Corporation, you will be required to sign an
Employee Disclosure, Assignment, Non-Compete and Non-Recruit Agreement (copy enclosed for your
perusal).

For clarification and protection of both you and the company, your acceptance of this offer
represents the sole agreement between you and Ceridian Corporation. No prior promises,
representations, or understandings relative to any terms or conditions of your employment are to be
considered as part of this agreement unless expressed in writing in this letter and the enclosed
Employee Disclosure, Assignment, Non-Compete and Non-Recruit Agreement. Ceridian asks that you
keep the terms of this offer confidential.

Enclosed you will find collateral materials providing more information regarding some of the
benefit and other plans.

 

 

Mr. Douglas C. Neve

Amended Offer Letter

December 6, 2004

Page 3

We are all looking forward to having you join Ceridian and to your positive contributions. If you
have any questions, feel free to call me at the office, 952/853-3301, or at home, 612/928-8944.
Please indicate your affirmative response by signing below and returning a copy to my attention.

Very truly yours,

Shirley J. Hughes

Enclosures (provided with original offer letter dated December 3, 2004)

cc: Ronald L. Turner

	 	 	 	 	 	 	 	 	 	 
	 
	 	Accepted:
	 	/s/ Douglas C. Neve
	 	Date:
	 	12/6/04	 
	 
	 	 	 	
 
	 	 	 	
 	 
	 
	 	 	 	Douglas C. Neve	 	 	 	 	 

 

 

Mr. Douglas C. Neve

Amended Offer Letter

December 6, 2004

Page 4

Enclosures (provided with original offer letter of December 3, 2004):

	•	 	Employee Disclosures, Assignment, Non-Compete and Non-Recruit Agreement
	•	 	Description of Equity Program – 2001 Long-Term Incentive Plan
	•	 	Description of Incentive Plans
	•	 	Officer Benefits Summary
	•	 	Executive Disability Pictorial Summary
	•	 	401(k) Plan Booklet
	•	 	Basic Health, Life, Dental Benefits:

	 	 	2004 Comparison Guide – Benefits
	 	 	2004 Benefits Handbook

	•	 	Deferred Compensation Plan
	•	 	Example of Executive Employment Agreement
	•	 	Code of Conduct<PAGE>
                                                                 EXHIBIT 10.17.1

                                  VIACELL, INC.

                                                   From the desk of Marc D. Beer
October 28, 2004                                   CEO

Gamete Technology, Inc.
1130 Ten Rod road
Suite E306
North Kingston, Rhode Island
Attention:  Nicholas H. Kondon

Thomas Toth, M.D.
11 Tavern Circle
Sudbury, MA 01776

Mehmet Toner, Ph.D
Shriners Burn Hospital
51 Blossom Street
Boston, MA 02114

Dear Nick, Tom and Mehmet:

I am writing to set forth the terms under which we have agreed to terminate the
Co-Development and License Agreement between ViaCell, Inc. ("ViaCell") and
Gamete Technology, Inc. ("Gamete") dated as of July 15, 2003 (the "Agreement")
and the Consulting Agreements between ViaCell and each of Drs. Toth and Toner
(the "Consulting Agreements"). We have agreed as follows:

      1.    The Agreement shall be terminated, effective as of November 7, 2004,
            with the effect described in Section 12.5 of the Agreement except as
            modified hereby.

      2.    The Consulting Agreements shall each be terminated, with the effect
            as set forth herein, effective as of November 7, 2004.

      3.    In lieu of any other payments that would otherwise be due under the
            Agreement or the Consulting Agreements, ViaCell shall, within
            fourteen (14) days of your countersignature to this letter, pay
            $175,000 to Gamete and $12,500 to each of Drs. Toth and Toner. This
            payment obligation shall survive the termination of the Agreement
            and the Consulting Agreements.

      4.    In accordance with Section 12.5 of the Agreement, ownership of all
            equipment currently at the Boston IVF and identified on Exhibit A
            hereto (the "Equipment") will be transferred to Gamete, and gamete
            agrees that the Equipment constitutes all of the equipment required
            to be transferred to Gamete under the Agreement.

             245 First Street - Fifteenth Floor - Cambridge, MA 02142
                      Phone 617 914 3555 - Fax 617 914 3855
<PAGE>
      5.    Each of Gamete, Dr. Toth and Dr. Toner agrees that the foregoing
            consideration represents settlement in full of all outstanding
            obligations owed to each of them by ViaCell. Gamete, ViaCell, Dr.
            Toth and Dr. Toner, on behalf of themselves, and their respective
            heirs, family members, executors, officers, directors, employees,
            inventors, shareholders, administrators, affiliates, divisions,
            subsidiaries, predecessor and successor corporations, and assigns,
            hereby fully and forever release each other and their respective
            heirs, family members, executors, officers, directors, employees,
            investors, shareholders, administrators, affiliates, divisions,
            subsidiaries, predecessor and successor corporations, and assigns,
            from, and agree not to sue concerning, any claim, duty, obligation
            or cause of action relating to any matters of any kind, whether
            presently known or unknown, suspected or unsuspected, that any of
            them may possess arising from any omissions, acts, or facts that
            have occurred up until and including the date that this letter is
            fully executed, without limitation, (a) any and all claims arising
            out of the Agreement and the termination of the Agreement, (b) any
            and all claims that were alleged or that could have been alleged, if
            any, and that have been filed, or will be filed, with any government
            body or arbitration body, (c) any and all claims will be filed, with
            any government body or arbitration body, (c) any and all claims
            (whether under federal, state law or otherwise, or the common law,
            statutory law or other legal authority of either) for termination in
            violation of public policy; breach of contract, both express and
            implied; breach of covenant of good faith and fair dealing, both
            express and implied; promissory estoppel; negligent or intentional
            misrepresentation; negligent or intentional interference with
            contract or prospective economic advantage; and unfair business
            practices; and (d) any and all claims for attorneys' fees and costs.
            Gamete, ViaCell, Dr. Toth and Dr. Toner agree that the release set
            forth in this paragraph shall be and remain in effect in all
            respects as a complete general release as to the matters released.
            This release does not extend to any obligations incurred under this
            letter agreement.

      6.    Except as modified hereby, the terms of the Agreement shall govern
            all aspects of the termination of the Agreement.

      7.    This letter agreement may be executed in one or more counterparts,
            all of which taken together shall be deemed one original. Facsimile
            signatures shall be deemed original.

      Please indicate your agreement with the terms of this letter by
countersigning a copy of this letter and returning it to me at your earliest
convenience.

                                        Very truly yours,

                                        VIACELL, INC.

                                        ------------------------------
                                        Marc Beer
                                        Chief Executive Officer

         AGREED:

         GAMETE TECHNOLOGY, INC.

         By: /s/ Nicholas H. Kondon              11/18/04
             --------------------------------------------
               Nicholas H. Kondon, Chief Executive Office
               Date:

/s/ Thomas L. Toth
-------------------
Thomas Toth, M.D.
Date:

/s/ Mehmet Toner
----------------
Mehmet Toner, Ph.D.
Date:

                                  VIACELL, INC.
       245 First Street - Fifteenth Floor - Cambridge, Massachusetts 02142
           Phone 617 914 3400 - Fax 617 577 9010 - www.viacellinc.com
<PAGE>
APPENDIX A - EQUIPMENT LIST

<TABLE>
<CAPTION>
       BOSTON IVF LAB INVENTORY
                 ITEM                                MANUFACTURER/VENDOR
--------------------------------------     -------------------------------------
<S>                                        <C>
                                           Olympus/Optical Analysis
                                           Narishige/Optical Analysis
                                           Thermo Plate/Optical Analysis
                                           Research Instruments/Zander Medical Supplies
                                           Olympus/Optical Analysis
                                           Harvard Instruments

            IMAGE ANALYSIS

HRC5005 0.5X Camera Coupler                Research Precision Instruments Company
MetaMorph Upgrade                          Research Precision Instruments Company
Z axis Controller                          Research Precision Instruments Company
Imaging Workstation                        Research Precision Instruments Company
Cool Snap Camera                           Research Precision Instruments Company
Line Conditioner                           Research Precision Instruments Company

                                           Cryologic/Biogenics*

             LAB EQUIPMENT

Co2 Icubator                               Thermo-Forma
SMZ800 Stereo Microscope                   Nikon/Micro Video Instruments
Heated stage for Stereo Microscope
Analytical Balance                         Mettler/Toledo
Ph Meter                                   Thermo Orion
Osmometer                                  Precision Systems
Desiccator Chamber
Stirring hot plate                         Isotemp/Fisher

           SUPPORT EQUIPMENT

Research Pipetter (3 total)                Eppendorf
Drummond pipetter
Hand Pump for filtration                   Nalgene
Eppendorf Easypet                          Eppendorf
Gooseneck Arm Illuminated Magnifier        Cole Parmer
</TABLE>

*Controlled rate freezer on order

Approved by

VIACELL Inc.                               Gamete Technologies, Inc.

                                                              11/18/04
--------------------------------------     -------------------------------------
<PAGE>
APPENDIX A - EQUIPMENT LIST

<TABLE>
<CAPTION>
           BOSTON IVF LAB INVENTORY
                     ITEM                              MANUFACTURER/VENDOR
---------------------------------------------    -------------------------------
<S>                                              <C>

               WORK STATION TWO

Inverted Phase Microscope w/fluorescence         Olympus/Optical Analysis
Micromanipulator System (hanging drop handle)    Narishige/Optical Analysis
Stage Warmer: Inverted Phase Microscope          Thermo Plate/Optical Analysis
RI SASSE "mushroom" Injector                     Research Instruments/Zander Medical Supplies
Kinetic System Isolation table                   Olympus/Optical Analysis
Harvard Apparatus PLI-100 Pico Injector          Harvard Instruments

                IMAGE ANALYSIS

HRC5005 o.5X Camera Coupler                      Research Precision Instruments Company
MetaMorph Upgrade                                Research Precision Instruments Company
Z axis Controller                                Research Precision Instruments Company
Imaging Workstation                              Research Precision Instruments Company
Cool Snap Camera                                 Research Precision Instruments Company
Line Conditioner                                 Research Precision Instruments Company

                CRYO EQUIPMENT

CONTROLLED RATE FREEZER                          CRYOLOGIC/BIOGENICS*

                LAB EQUIPMENT
Co2 Incubator                                    Thermo-Forma
SMZ800 Stereo Microscope                         Nikon/Micro Video Instruments
Heated stage for Stereo Microscope
Analytical Balance                               Mettler/Toledo
Ph Meter                                         Thermo Orion
Osmometer                                        Precision Systems
Desiccator Chamber
Stirring hot plate                               Isotemp/Fisher

              SUPPORT EQUIPMENT

Research Pipettor (3 total)                      Eppendorf
Drummond pipetter (2 total)
HandPump for filtration                          Nalgene
Eppendorf Easypet                                Eppendorf
Gooseneck Arm Illuminated Magnifier              Cole Parmer
</TABLE>
*Controlled Rte freezer on order

Approved by

VIACELL Inc.                                     Gamete Technologies Inc.

----------------------------------               -------------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]